2015
DOI: 10.3892/mmr.2015.4293
|View full text |Cite
|
Sign up to set email alerts
|

Apigenin attenuates myocardial ischemia/reperfusion injury via the inactivation of p38 mitogen-activated protein kinase

Abstract: Apigenin (Api) is a plant monomer associated with reducing the risk of heart disease. However, the mechanism of action remains to be fully elucidated. In the present study, it was hypothesized that API has cardioprotective effects by attenuating myocardial ischemia/reperfusion (I/R) injury. Rats were randomly subjected to sham operation, myocardial I/R alone or I/R + Api. Cardiac function was measured, and infarct size was evaluated by triphenyltetrazolium chloride staining following reperfusion. The myocardia… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
22
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(23 citation statements)
references
References 25 publications
1
22
0
Order By: Relevance
“…In a long-term study of diabetic cardiomyopathy in mice, apigenin administration improves left ventricular functions in the heart [ 40 ]. Apigenin also improves the recovery of cardiac function during ischemia/reperfusion injury of isolated rat heart using Langedorff system [ 23 ]. Thus, our data on apigenin-mediated recovery of myocardial injury and cardiac dysfunction may lead to potential therapeutic development in sepsis.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In a long-term study of diabetic cardiomyopathy in mice, apigenin administration improves left ventricular functions in the heart [ 40 ]. Apigenin also improves the recovery of cardiac function during ischemia/reperfusion injury of isolated rat heart using Langedorff system [ 23 ]. Thus, our data on apigenin-mediated recovery of myocardial injury and cardiac dysfunction may lead to potential therapeutic development in sepsis.…”
Section: Resultsmentioning
confidence: 99%
“…Cardioprotective effects of apigenin have been reported in numerous studies. Apigenin ameliorates myocardial ischemia/reperfusion injury via the inactivation of p38 mitogen-activated protein kinase [ 23 ]. Apigenin reduces the blood pressure, heart weight, heart weight index, cardiomyocyte cross-sectional area, and serum angiotensin II in a cardiac hypertrophy model via HIF-1 and PPAR α pathways [ 24 ].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, p38 inhibition with an antioxidant during ischemia–reperfusion is associated with improved cardiac recovery, decreased infarct size, and reduced apoptosis [ 66 ]. This was related to increased endogenous anti-oxidative enzyme activity and inhibition of oxidative stress [ 67 ]. The antioxidant Peroxiredoxin 1 and the ROS scavenger N-acetyl-l-cysteine have been also shown to decrease oxidative stress and block the activation of p38 and JNK, thus reducing apoptosis during ischemia–reperfusion [ 68 ].…”
Section: P38 In Ischemia–reperfusion Injurymentioning
confidence: 99%
“…In murine and rat models baicalein (30 mg/kg), apigenin (5 mg/kg) and vitexin (6, 3, 1.5 mg/kg) reduced I/R injury-induced infarct size, apoptosis, pro-inflammatory cytokines and oxidative stress [162,163,164]. Employing diabetic rats subjected to myocardial I/R, it has been assessed the protective effects of luteolin or breviscapine, a flavonoid extracted by Erigeron breviscapus .…”
Section: In Vivo Effects Of Polyphenols Against Oxidative Stress-imentioning
confidence: 99%